Resumen de acción FLRY3
Fleury S.A., junto con sus filiales, presta servicios médicos en las áreas de diagnóstico, tratamiento, análisis clínicos, gestión sanitaria, asistencia médica, ortopedia y oftalmología en Brasil.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Recompensas
Análisis de riesgos
Competidores de Fleury S.A.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | R$14.25 |
| 52 Week High | R$18.96 |
| 52 Week Low | R$13.69 |
| Beta | 0.59 |
| 1 Month Change | -0.70% |
| 3 Month Change | -4.55% |
| 1 Year Change | -8.95% |
| 3 Year Change | -43.26% |
| 5 Year Change | -28.75% |
| Change since IPO | 63.97% |
Noticias y actualizaciones recientes
The Price Is Right For Fleury S.A. (BVMF:FLRY3)
Apr 16
Concerns Surrounding Fleury's (BVMF:FLRY3) Performance
Mar 14Recent updates
The Price Is Right For Fleury S.A. (BVMF:FLRY3)
Apr 16Concerns Surrounding Fleury's (BVMF:FLRY3) Performance
Mar 14Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)
Jan 05Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet
Oct 05Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Jun 27We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt
Feb 25At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Sep 26Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Sep 08Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger
Jul 01When Should You Buy Fleury S.A. (BVMF:FLRY3)?
Jun 10Is Fleury (BVMF:FLRY3) Using Too Much Debt?
Apr 10Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing
Mar 24At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Feb 08Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)
Dec 08Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly
Nov 05Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?
Oct 21Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital
Aug 24Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly
Jul 31Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?
Jul 07Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Apr 30Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue
Apr 12At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?
Mar 29Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)
Mar 16Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend
Mar 01Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28What Type Of Shareholders Make Up Fleury S.A.'s (BVMF:FLRY3) Share Registry?
Feb 15Shareholders of Fleury (BVMF:FLRY3) Must Be Delighted With Their 360% Total Return
Feb 02
Three Days Left To Buy Fleury S.A. (BVMF:FLRY3) Before The Ex-Dividend Date
Jan 03Should We Be Excited About The Trends Of Returns At Fleury (BVMF:FLRY3)?
Dec 28Would Fleury S.A. (BVMF:FLRY3) Be Valuable To Income Investors?
Dec 12Taking A Look At Fleury S.A.'s (BVMF:FLRY3) ROE
Nov 29Getting In Cheap On Fleury S.A. (BVMF:FLRY3) Might Be Difficult
Aug 30Here's What You Should Know About Fleury S.A.'s (BVMF:FLRY3) 3.8% Dividend Yield
Aug 18Can Fleury S.A. (BVMF:FLRY3) Improve Its Returns?
Aug 03Could The Fleury S.A. (BVMF:FLRY3) Ownership Structure Tell Us Something Useful?
Jul 22Is Now The Time To Look At Buying Fleury S.A. (BVMF:FLRY3)?
Jul 10Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
Jun 25Rentabilidad de los accionistas
| FLRY3 | BR Healthcare | Mercado BR | |
|---|---|---|---|
| 7D | -1.2% | -1.5% | -1.6% |
| 1Y | -8.9% | -24.7% | -4.5% |
Rentabilidad vs. Industria: FLRY3 superó a la industria BR Healthcare, que obtuvo un rendimiento del -10.2% el año pasado.
Rentabilidad vs. Mercado: FLRY3 obtuvo unos resultados inferiores a los del mercado BR, que fue del 13.9% el año pasado.
Volatilidad de los precios
| FLRY3 volatility | |
|---|---|
| FLRY3 Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 9.3% |
| 10% least volatile stocks in BR Market | 2.2% |
Precio estable de las acciones: FLRY3 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de FLRY3 (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1926 | 27,300 | Jeane Tsutsui | ri.fleury.com.br |
Fleury S.A., junto con sus filiales, presta servicios médicos en las áreas de diagnóstico, tratamiento, análisis clínicos, gestión sanitaria, asistencia médica, ortopedia y oftalmología en Brasil. La empresa opera a través de tres segmentos: Medicina Diagnóstica, Medicina Integrada y Odontología. Ofrece pruebas de laboratorio e imagen, genómica, gestión y plataforma de salud, información diagnóstica, laboratorio de chequeo y referencia, clínica de día, centro de infusión, ortopedia y oftalmología, pruebas de imagen dental y servicios de diagnóstico por imagen.
Resumen de fundamentos de Fleury S.A.
| Estadísticas fundamentales de FLRY3 | |
|---|---|
| Capitalización bursátil | R$7.77b |
| Beneficios(TTM) | R$497.87m |
| Ingresos (TTM) | R$7.14b |
15.6x
Ratio precio-beneficio (PE)1.1x
Ratio precio-ventas (PS)¿Está FLRY3 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de FLRY3 | |
|---|---|
| Ingresos | R$7.14b |
| Coste de los ingresos | R$5.20b |
| Beneficio bruto | R$1.93b |
| Otros gastos | R$1.44b |
| Beneficios | R$497.87m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Aug 08, 2024
| Beneficios por acción (BPA) | 0.91 |
| Margen bruto | 27.09% |
| Margen de beneficio neto | 6.97% |
| Ratio deuda/patrimonio | 54.1% |
¿Cómo se ha desempeñado FLRY3 a largo plazo?
Ver rendimiento histórico y comparativa